Publication

2018

Kelly KR, Espitia CM, Zhao W, Wu K, Visconte V, Anwer F, Calton CM, Carew JS, Nawrocki ST. 2018. Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy. Leukemia. 32:230–233. doi:10.1038/leu.2017.272.
Chipollini J, Necchi A, Spiess PE. 2018. Outcomes for Patients with Node-positive Penile Cancer: Impact of Perioperative Systemic Therapies and the Importance of Surgical Intervention. Eur Urol. 74:241–242. doi:10.1016/j.eururo.2018.04.025.
Pozo K, Zahler S, Ithimatsu K, Carter A, Telange R, Wang S, Pfragner R, Fujimoto J, Grubbs E, Takahashi M, et al. 2018. Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer, Oncotarget, 9: 37662-37675.